Updated Quarterly (4 updates annually) to Reflect Market Changes
Over 2800 Data Points
Over two decades of publishing in vitro diagnostic market research, Kalorama Information has heard from customers: IVD is a global industry, growth is global and our customers want more geographic coverage. Regional coverage is useful for some activities, but regions don’t tell the whole story. Country level is needed.
As a result, we are offering geographic research and analysis focused at the country, rather than regional level in our 30 Country In Vitro Diagnostics (IVD) Market Atlas. A quarterly-updated, 30-country market research report with the major IVD segments forecasted out five years.
To replicate the 2800+ data points in the IVD Market Atlas, you’d need to buy dozens of other companies market research studies.
This quarterly updated report contains IVD markets aligned to Kalorama’s expert global estimates in our Worldwide Market for In Vitro Diagnostics, segmented for 30 important country markets and for 19 key test segments.
Global country market coverage includes:
Australia
Austria
Belgium
Brazil
Canada
Chile
China
Egypt
France
Germany
India
Indonesia
Italy
Japan
Mexico
Netherlands
Poland
Romania
Russia
Saudi Arabia
South Africa
South Korea
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
United States
Vietnam
Market researchers will tend to sell reports for each of these countries, rather than combine in one report. For Kalorama, our mission is different. We seek to keep companies informed with useful references when they need it, rather than publish hundreds of reports a year. [We tend to publish 30 or less]. The IVD Market Atlas reflects this mission.
It’s important to note that for each of these countries, there is an overall IVD market estimate and then, the most important market segments are broken out. These include:
Blood Bank Immunoassays
Blood Bank Molecular (NAT)
Clinical Chemistry
Coagulation
COVID-19
Critical Care
FOB
Glucose
Hematology
Histology/Cytology
ID/AST Microbiology
Immunoassays
Immunoassays, Micro
Molecular, Micro
Molecular, Others
Overall Country IVD
Point of Care
POC Infectious Disease
Pregnancy Testing
While these are not every segment possible, they are the most important [most searched for/requested and largest] IVD market segments.
The report is updated every 3 months. Why? This is to keep up with market changes. It was once the case that the IVD market didn’t change rapidly. COVID-19, international changes, M&A activity, new products, point of care trends and regulatory activity have all worked together to change that. While there may not be substantial change in markets between one quarter and another, the report will catch segment changes, and you will always have an updated data set for your business planning.
Those who subscribe will be placed on our Knowledge Center product and will receive quarterly updates.
Table of Contents
Chapter One: Worldwide IVD Market
IVD Market Demand and Growth
Scope and Methodology
Market Segmentation
Country Atlas Scope
Table 1-1: Key Interest Countries (30-Country Atlas) for IVD Markets, 2022
Chapter Two: United States
U.S. IVD Market Overview
Table 2-1: U.S. IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)
Chapter Three: Germany
Germany IVD Market Overview
Table 3-1: Germany IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)
Chapter Four: Japan
Japan IVD Market Overview
Table 4-1: Japan IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)
Chapter Five: China
China IVD Market Overview
Table 5-1: China IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)
Chapter Six: France
France IVD Market Overview
Table 6-1: France IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)
Chapter Seven: United Kingdom
United Kingdom IVD Market Overview
Table 7-1: United Kingdom IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)
Chapter Eight: Italy
Italy IVD Market Overview
Table 8-1: Italy IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)
Chapter Nine: Canada
Canada IVD Market Overview
Table 9-1: Canada IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)
Chapter Ten: Spain
Spain IVD Market Overview
Table 10-1: Spain IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)
Chapter Eleven: Australia
Australia IVD Market Overview
Table 11-1: Australia IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)
Chapter Twelve: Brazil
Brazil IVD Market Overview
Table 12-1: Brazil IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)
Chapter Thirteen: Russia
Russia IVD Market Overview
Table 13-1: Russia IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)
Chapter Fourteen: India
India IVD Market Overview
Table 14-1: India IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)
Chapter Fifteen: Switzerland
Switzerland IVD Market Overview
Table 15-1: Switzerland IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)
Chapter Sixteen: Netherlands
Netherlands IVD Market Overview
Table 16-1: Netherlands IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)
Chapter Seventeen: Poland
Poland IVD Market Overview
Table 17-1: Poland IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)
Chapter Eighteen: Turkey
Turkey IVD Market Overview
Table 18-1: Turkey IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)
Chapter Nineteen: Sweden
Sweden IVD Market Overview
Table 19-1: Sweden IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)
Chapter Twenty: Belgium
Belgium IVD Market Overview
Table 20-1: Belgium IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)
Chapter Twenty-One: Mexico
Mexico IVD Market Overview
Table 21-1: Mexico IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)
Chapter Twenty-Two: Austria
Austria IVD Market Overview
Table 22-1: Austria IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)
Chapter Twenty-Three: Saudi Arabia
Saudi Arabia IVD Market Overview
Table 23-1: Saudi Arabia IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)
Chapter Twenty-Four: South Korea
South Korea IVD Market Overview
Table 24-1: South Korea IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)
Chapter Twenty-Five: Romania
Romania IVD Market Overview
Table 25-1: Romania IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)
Chapter Twenty-Six: Egypt
Egypt IVD Market Overview
Table 26-1: Egypt IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)
Chapter Twenty-Seven: Indonesia
Indonesia IVD Market Overview
Table 27-1: Indonesia IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)
Chapter Twenty-Eight: Chile
Chile IVD Market Overview
Table 28-1: Chile IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)
Chapter Twenty-Nine: South Africa
South Africa IVD Market Overview
Table 29-1: South Africa IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)
Chapter Thirty: United Arab Emirates
United Arab Emirates IVD Overview
Table 30-1: United Arab Emirates IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)
Chapter Thirty-One: Vietnam
Vietnam IVD Market Overview
Table 31-1: Vietnam IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)
